Feature

U.S. flu activity already at mid-season levels


 

Reports of respiratory illness continued to rise as the 2022-23 flu season maintained its early surge through mid-November, according to the Centers of Disease Control and Prevention.

Nationally, 6% of all outpatient visits were because of flu or flu-like illness for the week of Nov. 13-19, up from 5.8% the previous week, the CDC’s Influenza Division said in its weekly FluView report.

Proportion of outpatient visits for influenza-like illness by week

Those figures are the highest recorded in November since 2009, but the peak of the 2009-10 flu season occurred even earlier – the week of Oct. 18-24 – and the rate of flu-like illness had already dropped to just over 4.0% by Nov. 15-21 that year and continued to drop thereafter.

Although COVID-19 and respiratory syncytial virus (RSV) are included in the data from the CDC’s Outpatient Influenza-like Illness Surveillance Network, the agency did note that “seasonal influenza activity is elevated across the country” and estimated that “there have been at least 6.2 million illnesses, 53,000 hospitalizations, and 2,900 deaths from flu” during the 2022-23 season.

Total flu deaths include 11 reported in children as of Nov. 19, and children ages 0-4 had a higher proportion of visits for flu like-illness than other age groups.

The agency also said the cumulative hospitalization rate of 11.3 per 100,000 population “is higher than the rate observed in [the corresponding week of] every previous season since 2010-2011.” Adults 65 years and older have the highest cumulative rate, 25.9 per 100,000, for this year, compared with 20.7 for children 0-4; 11.1 for adults 50-64; 10.3 for children 5-17; and 5.6 for adults 18-49 years old, the CDC said.

A version of this article first appeared on WebMD.com.

Recommended Reading

What’s the best age to stop smoking? Study offers clue
Clinician Reviews
Metabolites may distinguish severe subtypes of PAH
Clinician Reviews
Mid-October flulike illness cases higher than past 5 years
Clinician Reviews
COVID bivalent booster better vs. recent Omicron subvariants: Pfizer
Clinician Reviews
Man with COVID finally tests negative after 411 days
Clinician Reviews
CDC warns of early uptick in respiratory disease
Clinician Reviews
‘A huge deal’: Millions have long COVID, and more are expected
Clinician Reviews
Flu vaccination associated with reduced stroke risk
Clinician Reviews
The right indoor relative humidity could ward off COVID
Clinician Reviews
More vaccinated people dying of COVID as fewer get booster shots
Clinician Reviews